With the Senate’s confirmation of Alvaro Bedoya to the Federal Trade Commission on May 11, Democrats now have a 3-2 majority in the FTC, which will likely lead to heightened scrutiny of competition in healthcare, Paul Keckley, PhD, wrote May 16 in The Keckley Report.
